KOEHLER eClinical Expands in Germany
Koehler eClinical, a specialty contract research organization, is excited to announce that due to growth and high customer loyalty, its expansion continues with the opening of new offices in Mannheim, Germany effective January 2020.
The Mannheim office will support the growth in our core business area biostatistics and programming, with an initial team of 5 Biostatisticians and Statistical Programmers that come with a track record of having worked successfully together for years at Prometris GmbH.
“We are excited to expand our biometrics division with this very experienced group from Prometris, who wished to continue working together as a team, and are also particularly grateful to the Prometris management for their dedicated support in making this possible.” said Dr. Antal K. Hajos, CEO of Koehler eClinical. “We are pleased that the former Prometris Biostatistics Department has found a good new home together at Koehler eClinical.”, says Steffen Koenig, CRO of Prometris and IST GmbH.
The opening of the new Mannheim office, the 4thlocation of Koehler eClinical offices after Berlin, Constance and the headquarter office in Freiburg, follows the management handover in July last year to Michael Pfitzenmaier and Dr. Antal K. Hajos as new CEOs by Dr. Manfred Köhler, who remains as sole owner and Chair of the Board.
Gilead Shares Final Data from Phase III MYR301 Trial of Bulevirtide in Chronic Hepatitis Delta Virus
May 7th 2025Long-term results from the study show 90% of patients with chronic HDV who achieved undetectable HDV RNA at 96 weeks of treatment remained undetectable for nearly 2 years post-treatment.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
